文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

不同跨肺压导向机械通气对ARDS患者呼吸及血流动力学的影响:前瞻性随机对照试验

[Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论跨肺压10 cmH2O导向机械通气可改善ARDS患者氧合与呼吸力学且对血流动力学影响较小,但28天死亡率无显著差异。

该前瞻性随机对照试验纳入64例完成研究的ARDS患者,观察组43例按跨肺压10、15、20 cmH2O三个亚组导向机械通气,对照组21例按ARDSNet导向通气。通气48小时时,跨肺压20 cmH2O亚组PaO2/FiO2、PEEP、Pplat、Cst显著高于对照组,ELWI显著降低,但MAP、CI、GEDVI也显著降低;跨肺压10 cmH2O亚组同样改善氧合和呼吸力学且ELWI降低,但MAP、CI、GEDVI与对照组无显著差异。跨肺压10 cmH2O和15 cmH2O亚组机械通气时间及ICU住院时间与对照组无显著差异,20 cmH2O亚组数值上缩短但原文P>0.05。各组28天死亡率无显著差异。作者认为跨肺压10 cmH2O导向通气是安全有效的心肺保护性通气方法。

要点

  • ARDS患者以跨肺压10 cmH2O导向通气48小时,PaO2/FiO2 183.4±45.5 mmHg vs 对照组178.5±42.9 mmHg,PEEP 14.4±3.6 cmH2O vs 6.6±2.2 cmH2O,Cst 16.2±4.3 mL/cmH2O vs 13.1±4.6 mL/cmH2O,均P<0.05。
  • 跨肺压20 cmH2O亚组通气48小时氧合和呼吸力学改善更明显,但MAP 58.8±6.7 mmHg vs 对照组69.7±4.7 mmHg、CI 46.7±23.3 mL×s-1×m-2 vs 73.3±30.0 mL×s-1×m-2、GEDVI 633.2±45.2 mL/m2 vs 702.6±55.7 mL/m2均显著降低(均P<0.05)。
  • 跨肺压10 cmH2O亚组ELWI 8.7±1.8 mL/kg vs 对照组10.8±2.6 mL/kg显著降低(P<0.05),而MAP、CI、GEDVI与对照组无显著差异(均P>0.05)。
  • 跨肺压10 cmH2O和15 cmH2O亚组机械通气时间及ICU住院时间与对照组无显著差异,20 cmH2O亚组数值上缩短但原文P>0.05;各组28天死亡率无显著差异。
  • 作者认为跨肺压10 cmH2O导向机械通气可改善氧合和呼吸力学且对血流动力学影响较小,是安全有效的心肺保护性通气方法。

适用人群与场景

  • 2013年2月至2016年8月广州医科大学附属深圳沙井医院重症医学科(ICU)和南方医科大学深圳医院急诊与重症医学科(EICU)收治的接受机械通气的ARDS患者。
  • 最终完成研究64例,观察组43例,对照组21例;入组67例中2例48小时内死亡、1例失访。

处置流程与药物剂量

  • 所有患者按ARDS国际指南接受标准治疗。
  • 对照组按ARDSNet导向进行机械通气;观察组按不同跨肺压导向进行机械通气,并分为跨肺压10、15、20 cmH2O(1 cmH2O=0.098 kPa)三个亚组。
  • 在机械通气过程中设定不同跨肺压后1、24、48小时测定呼吸功能参数,并用脉搏指示连续心排血量(PiCCO)技术测定血流动力学参数。

研究设计与关键结果

  • 前瞻性随机对照试验,最终完成64例ARDS患者,观察组43例、对照组21例;两组性别构成、年龄、入院4小时内氧合指数(PaO2/FiO2)和急性生理学与慢性健康状况评分Ⅱ(APACHEⅡ)基线均衡可比。
  • 对照组各时间点呼吸功能和血流动力学参数无明显变化;观察组随通气时间延长呼吸功能显著改善,跨肺压逐渐升高对血流动力学参数有明显不良影响。
  • 通气48小时设定跨肺压后,跨肺压20 cmH2O亚组较对照组PaO2/FiO2(220.9±30.8 mmHg vs 178.5±42.9 mmHg)、PaCO2(55.1±7.6 mmHg vs 38.6±4.8 mmHg)、PEEP(24.7±4.8 cmH2O vs 6.6±2.2 cmH2O)、Pplat(34.4±3.7 cmH2O vs 20.7±3.5 cmH2O)、Cst(23.8±3.6 mL/cmH2O vs 13.1±4.6 mL/cmH2O)均显著升高(均P<0.05),ELWI显著降低(6.8±1.7 mL/kg vs 10.8±2.6 mL/kg,P<0.05),但MAP(58.8±6.7 mmHg vs 69.7±4.7 mmHg)、CI(46.7±23.3 mL×s-1×m-2 vs 73.3±30.0 mL×s-1×m-2)、GEDVI(633.2±45.
  • 跨肺压10 cmH2O亚组较对照组PaO2/FiO2(183.4±45.5 mmHg vs 178.5±42.9 mmHg)、PEEP(14.4±3.6 cmH2O vs 6.6±2.2 cmH2O)、Pplat(25.7±5.6 cmH2O vs 20.7±3.5 cmH2O)、Cst(16.2±4.3 mL/cmH2O vs 13.1±4.6 mL/cmH2O)均显著升高(均P<0.05),ELWI显著降低(8.7±1.8 mL/kg vs 10.8±2.6 mL/kg,P<0.05),但MAP(65.8±4.6 mmHg vs 69.7±4.7 mmHg)、CI(65.0±35.0 mL×s-1×m-2 vs 73.3±30.0 mL×s-1×m-2)、GEDVI(706.7±54.4 mL/m2 vs 702.6±55.7 mL/m2)无显著差异(均P>0.05)。
  • 跨肺压10 cmH2O亚组与15 cmH2O亚组机械通气时间和ICU住院时间与对照组无显著差异;20 cmH2O亚组机械通气时间(95.5±21.5天 vs 130.8±23.6天)和ICU住院时间(8.1±2.2天 vs 12.8±2.8天)数值上缩短,但原文P>0.05。
  • 各组28天死亡率无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性随机对照试验(RCT)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为跨肺压10 cmH2O导向机械通气可改善氧合和呼吸力学且对血流动力学影响较小,是安全有效的心肺保护性通气方法。
  • 跨肺压20 cmH2O导向通气虽改善氧合和呼吸力学更明显,但MAP、CI、GEDVI显著降低,对血流动力学有明显不良影响。
  • 跨肺压10 cmH2O和15 cmH2O导向通气未显示缩短机械通气时间和ICU住院时间,20 cmH2O亚组数值上缩短但原文P>0.05。
  • 各组28天死亡率无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To assess the effect of different transpulmonary pressures (Ptp) guided mechanical ventilation (MV) on respiratory function and hemodynamics parameters of patients with acute respiratory distress syndrome (ARDS), and to find out a more optimized Ptp.

METHODS: A prospective randomized controlled trial (RCT) was conducted. The ventilated patients with ARDS admitted to Department of Critical Care Medicine (ICU) of Shenzhen Shajing Affiliated Hospital of Guangzhou Medical University and Department of Emergency and Critical Care Medicine (EICU) of Shenzhen Hospital of South Medical University from February 2013 to August 2016 were enrolled. According to random number table method, all patients were divided into control group and observation group. The patients in observation group was subdivided into three subgroups according to the different setting of Ptp, namely Ptp 10, 15, 20 cmH2O (1 cmH2O = 0.098 kPa) subgroups. The patients in all groups received standard treatment in accordance with the international guidelines for ARDS. The patients in control group were ventilated by guidance of ARDSNet, and the patients in observation group were ventilated by guidance of different Ptp. After setting different Ptp at 1, 24, 48 hours in the process of MV, respiratory function parameters of patients in all groups were determined. The hemodynamic parameters were determined by using pulse indicating continuous cardiac output (PiCCO) technology. The duration of MV, length of ICU stay and 28-day mortality were recorded.

RESULTS: A total of 67 patients with ARDS were enrolled, among whom 2 patients died within 48 hours, and 1 case was lost to follow-up. Finally, 64 patients completed the study, 43 patients in observation group, and 21 in control group. There were no significant differences in gender composition, age, oxygenation index (PaO2/FiO2) within 4 hours after hospital admission and acute physiology and chronic health evaluation II (APACHE II) score between the two groups, which showed the baseline was equivalent and comparable. The respiratory function and hemodynamic parameters showed no obvious change in control group at different time points of MV; but with the extension of ventilation, the respiratory function was improved significantly in observation group, and the gradually rising of Ptp had obvious adverse effects on hemodynamics parameters. Compared with control group, at 48 hours of ventilation after setting Ptp, the respiratory function in Ptp 20 cmH2O subgroup was improved significantly, PaO2/FiO2, arterial partial pressure of carbon dioxide (PaCO2), positive end-expiratory pressure (PEEP), airway platform pressure (Pplat), and lung compliance (Cst) were significantly increased [PaO2/FiO2 (mmHg, 1 mmHg = 0.133 kPa): 220.9±30.8 vs. 178.5±42.9, PaCO2 (mmHg): 55.1±7.6 vs. 38.6±4.8, PEEP (cmH2O): 24.7±4.8 vs. 6.6±2.2, Pplat (cmH2O): 34.4±3.7 vs. 20.7±3.5, Cst (mL/cmH2O): 23.8±3.6 vs. 13.1±4.6; all P < 0.05], and extravascular lung water index (ELWI) was significantly decreased (mL/kg: 6.8±1.7 vs. 10.8±2.6, P < 0.05), but mean artery pressure (MAP), cardiac index (CI), global end-diastolic volume index (GEDVI) such as hemodynamics parameters were also significantly reduced [MAP (mmHg): 58.8±6.7 vs. 69.7±4.7, CI (mL×s-1×m-2): 46.7±23.3 vs. 73.3±30.0, GEDVI (mL/m2): 633.2±45.2 vs. 702.6±55.7; all P < 0.05]; the PaO2/FiO2, PEEP, Pplat, and Cst in Ptp 10 cmH2O subgroup were significantly increased [PaO2/FiO2 (mmHg): 183.4±45.5 vs. 178.5±42.9, PEEP (cmH2O): 14.4±3.6 vs. 6.6±2.2, Pplat (cmH2O): 25.7±5.6 vs. 20.7±3.5, Cst (mL/cmH2O): 16.2±4.3 vs. 13.1±4.6; all P < 0.05], and ELWI was significantly reduced (mL/kg: 8.7±1.8 vs. 10.8±2.6, P < 0.05), but the MAP, CI and GEDVI showed no significant difference [MAP (mmHg): 65.8±4.6 vs. 69.7±4.7, CI (mL×s-1×m-2): 65.0±35.0 vs. 73.3±30.0, GEDVI (mL/m2): 706.7±54.4 vs. 702.6±55.7; all P > 0.05]. The above illustrated that 10 cmH2O Ptp could act as the same as 20 cmH2O did to improve oxygenation and respiratory function, but had no obvious effect on hemodynamics. Compared with control group, the duration of MV and the length of ICU stay showed no significant differences in Ptp 10 cmH2O and 15 cmH2O subgroups, but those in 20 cmH2O subgroup were significantly shortened [duration of MV (days): 95.5±21.5 vs. 130.8±23.6, length of ICU stay (days): 8.1±2.2 vs. 12.8±2.8, both P > 0.05]. There was no significant difference in 28-day mortality among the groups.

CONCLUSIONS: MV guided by Ptp of 10 cmH2O could improve oxygenation and respiratory mechanics, while has less hemodynamic influence. It was a safe and effective cardiopulmonary protection ventilation method.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li J, Luo Z, Li X, et al. [Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28459402. doi:10.3760/cma.j.issn.2095-4352.2017.01.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。